Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound
2022年10月7日 - 3:00PM
JCN Newswire
Olympus Corporation (Olympus), a global medtech company
committed to making people's lives healthier, safer and more
fulfilling, today announced the launch of EU-ME3, a new Endoscopic
Ultrasound Processor*, which addresses the needs of healthcare
professionals for high-quality clear images when conducting the
endoscopic ultrasound procedure. EU-ME3 will be launched in Europe,
the Middle East, Africa, parts of Asia, and Oceania within this
fiscal year. EU-ME3 will be exhibited during The 30th United
European Gastroenterology Week (UEG Week) from October 8 to 11.
As a pioneer in endoscopic ultrasound technology, Olympus aims to
leverage its expertise to enhance the care pathway in
gastrointestinal and respiratory disease management. The technology
is used for endoscopic ultrasonography (EUS) imaging to support the
diagnosis of lesions in the pancreas, the bile ducts, or lesions
that are located deep inside the body and are not visible with
gastrointestinal endoscopes. In addition, the technology enhances
the detailed examination of pancreatitis, pancreatic cancer, and
the diagnosis of cancer invasion in the stomach and the esophagus.
Endoscopic ultrasound also plays a key role in facilitating the
visualization of endobronchial ultrasound-guided transbronchial
needle aspiration (EBUS-TBNA) for early, minimally invasive
diagnosis and lung cancer staging.
"It is said that pancreatic cancer is difficult to be detected in
its early stages, and that lung cancer has the highest mortality
rate among all cancers. With the launch of the EU-ME3, Olympus aims
to enhance the standard of care including these diseases and to
further improve the quality of life of patients," said Hironobu
Kawano, Head of Endoscopic Solutions Division at Olympus.
Advancing the dimensions of Endosonography
With the needs of healthcare professionals and patient outcomes at
the core, EU-ME3 is tailored to improve a variety of
procedures.
Enhanced visualization and usability
EU-ME3 provides outstanding image quality and functionality - the
image quality has been substantially enhanced compared to the prior
generation model (EU-ME2), providing enhanced visualization, and
therefore supporting more reliable diagnosis and treatment. Shear
Wave Quantification, a newly equipped feature for EU-ME3, also
contributes to accurate diagnosis by providing quantitative
information on the stiffness of tumor and inflamed lesions, which
is an important factor when diagnosing a degree of pancreatitis and
malignancy of pancreatic cancer during endoscopic
ultrasonography.
Focus on the procedure with tailored technology
The Endoscopic ultrasound procedure typically utilizes a variety of
observation modes dependent on procedure type or clinical area.
Subsequently, in addition to the basic observation mode, EU-ME3
offers multiple software options for individual clinical needs,
aiming to stay flexible in the selection of functions and tailor
EU-ME3 depending on specialty. Smart and customizable user settings
make it easy to fulfil needs for multiple specialties and personal
requirements. The backlit keyboard includes a simple, easy-to-use
large touch panel and trackpad, designed to support better
operability and easier cleaning.
With EU-ME3, the aim is to provide seamless workflow integration
for our partners while advancing the dimensions of endosonography
for better overall patient outcome.
About Olympus
In its Endoscopic Solutions business, Olympus uses innovative
capabilities in medical technology, therapeutic intervention and
precision manufacturing to help healthcare professionals deliver
diagnostic, therapeutic and minimally invasive procedures to
improve clinical outcomes, reduce overall costs and enhance the
quality of life for patients. Starting with the world's first
gastrocamera in 1950, Olympus' Endoscopic Solutions portfolio has
grown to include endoscopes, laparoscopes, and video imaging
systems, digital and integrated customer solutions, as well as
solutions for infection prevention. For more information, visit
www.olympus-global.com and follow our global Twitter account:
@Olympus_Corp.
Media Contacts
Nao Tsukamoto - Global-Public_Relations@olympus.com
Jessica Lee - Jessica.yy.lee@fleishman.com
* Registered name: EVIS EUS ENDOSCOPIC ULTRASOUND CENTER OLYMPUS
EU-ME3. EU-ME3 is manufactured by Olympus Medical Systems
Corporation.
* Note: Products or devices presented include future technology
which may be pending regional regulatory approval and are not
available for sale in all regions.
Olympus Corp [TYO: 7733] [ADR: OCPNY] [GDR: OLYs]
https://www.olympus-global.com
Copyright 2022 JCN Newswire . All rights reserved.